Dasotraline Adult ADHD Study

NCT02276209 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

636

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Dasotraline
DRUG: Dasotraline
OTHER: Placebo

Sponsor

Sumitomo Pharma America, Inc.